IAPO Logo High Resolution
HI! from the IAPO (International Alliance of Patients Organisations) Global Patients Conference 2016!

I’m representing Lupus Europe at this amazing conference!   From www.iapo.org.uk  “150 patients’ advocates from 48 countries are meeting in London to discuss how innovation can help achieve universal, patient-centred and sustainable access to healthcare around the world.”

My objective here was to represent Lupus Europe (we are a voting member), and give visibility to lupus.

–> I have been tweeting as lupuseurope (just during this conference, usually it’s Nuria!) using the hashtag #GPC2016 and #lupus, so you can look through the tweets and see some photos and other quotes from the days.

It’s been very rich agenda so far.   Monday we started with what they called a “Speed-up dating” which was a fun meet and greet. We had two minutes to one person and we had to learn about each other. I met 15 people/groups in 30 mins! I think it’s a great idea to break the ice! 

Then we had the AGM where we heard old business, financials and elected five (!) new board members.

We heard from Jolanta Bilinska (Governing Board Chair) about IAPOs objectives, and Kahwaldip Sehmi, IAPO CEO, about his road to IAPO (he had such good care with his illness that he wanted to make sure everyone could have the same!)
They listed IAPO’s goals as:
Help patients’ organizations to be as effective as possible
Be the leading patients voice on health issues
Empower the global patient movement

They talked about how the UK Charity laws have changed, there are new ways of presenting budgets, and so that took time to adapt.

Keynote speaker: Nicolas Sireau gave a very inspiring speech, about Fundamental Diseases (he has two children with Black Bone disease, an ultra rare disease) It’s on Ted Talk so you can see what he has to say about why it’s so important to study rare diseases: https://www.youtube.com/watch?v=B4UnVlU5hAY

We had a talk from Professor Peter Boyle on the challenge of rising global cancer rates, particularity in lower and middle-class income countries.  He said we had to consider the patients, giving many memorable quotes, such as “statistics are patients with the tears wiped away.”

Then we had Workshops.  I was part of the workshop, “Building effective and innovative networks and campaigns for greater impact.” and presented the Patient Panel work on Adherence to Treatment done by Alain, Bernadette, Davide and Jeanette (among others) in 2014.  The presentation was really well received and so many people were impressed by the work done (well done team!!)

Penny Cowan, American Chronic Pain organisation, gave a really impressive talk about new tools they have invented and are trying to get passed to talk to doctors about pain.  I am sure we could do an excellent adaptation of one for lupus!  They are all available for download from https://theacpa.org/Communication-Tools

There was also an interesting talk from Mattias Wienold, European Aids Treatment Group, and summaries of the other workshops.  All talked about how we need to focus on the patients and the patients need to have endless persistence to get the results they want!

The presentation brought several people to come to talk to me about our lupus work.

End of Day one on Saturday evening – I’ll write about today’s meeting and some of the interesting people I met later or tomorrow.
Thinking of your all!
Anne

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

🧠 As lupus specialist Prof Laurent Arnaud clearly states, “Your experience of brain fog is real. It is common. It deserves attention.”

That is why the Lupus Brain Fog Severity Scale (LBFSS) was developed: to provide a lupus-specific way to assess the severity and impact of brain fog and related cognitive symptoms.

Importantly, people living with lupus were not simply asked to approve a finished questionnaire. Their own descriptions of brain fog were the starting point for its development.

🎥 Watch Prof Laurent Arnaud and our Chair, Jeanette Andersen, explain how people living with lupus helped shape the #LBFSS from the very beginning.

🦋 Lupus Europe is proud to have contributed to this international work and to have supported meaningful patient involvement throughout the development process.

📖 Read the study:
lupus.bmj.com/content/13/2/e002148
... See MoreSee Less

‼️Today is #WorldSjogrensDay, a chronic autoimmune disease that affects 14-17.8% of #lupus patients.

💁‍♀️ Although Sjögren's is a systemic disease that goes far beyond dryness, dryness remains a frequent, significant and disabling symptom.

➡️ Follow Sjögren Europe to know more.
... See MoreSee Less

‼️Today is #Worl

🧠 Brain fog is real.

For many people living with lupus, it affects everyday life, yet it has often remained difficult to measure.

✅ The new Lupus Brain Fog Severity Scale (LBFSS) is the first questionnaire designed specifically to assess brain fog in lupus.

🦋 Lupus Europe is proud to have contributed to its development through meaningful involvement of people living with lupus. It's another example of how patient perspectives help shape better research and better tools.

🎥 Watch Prof Laurent Arnaud and our Chair, Jeanette Andersen, explain why the LBFSS is such an important step forward in lupus care.

lupus.bmj.com/content/lupusscimed/13/2/e002148.full.pdf
... See MoreSee Less

🦋 Understanding lupus is crucial for effective management and self-management.

💁‍♀️ Many of us know what lupus is, and we’ve been learning from trusted resources like #Lupus100 and #LupusGPT.

🤔 But… how much do we really know about SLE?
Do we know as much as we think we do?

𝐓𝐫𝐲 #𝐒𝐋𝐀𝐊𝐄 𝐚𝐧𝐝 𝐟𝐢𝐧𝐝 𝐨𝐮𝐭❗

🎯 SLAKE (Systemic Lupus Assessment score for Essential Knowledge) is a quick and easy online tool designed for people living with lupus to test their knowledge and learn more about the disease.

📝 44 questions, randomly selected from a pool of 394
⏱️ Around 15 minutes to complete
🌍 Available in 20 languages
📊 A score for each lupus domain and an overall knowledge score

💡 Whether you're newly diagnosed or have been living with lupus for years, SLAKE helps you identify what you already know and where there is room to grow. It is not about passing or failing. It is a chance to learn more and feel more confident when taking part in decisions about your health.

📣 The SLAKE study is still open! By taking part, you are helping researchers understand which aspects of lupus are well understood and where important knowledge gaps remain.

These insights could help guide the potential development of better information resources and tools, tailored to the real needs of people living with lupus in different countries and regions.

SLAKE has been made possible thanks to the leadership of Prof Laurent Arnaud and Dr Antonin Satrin, and the collaboration of an international team of lupus experts and patient representatives.

🥰 Lupus Europe has proudly contributed to this project since the very beginning, and we encourage people living with lupus worldwide to take part while the study remains open.

🔗 Complete SLAKE today and let us know what you think!

lupusresearch.limequery.org/775349
... See MoreSee Less

LUPUS EUROPE Uniting people with Lupus throughout Europe
Send